FI863471A - Förfarande för framställning av terapeutiskt användbara 3-desmetylmevalonsyraderivat - Google Patents

Förfarande för framställning av terapeutiskt användbara 3-desmetylmevalonsyraderivat Download PDF

Info

Publication number
FI863471A
FI863471A FI863471A FI863471A FI863471A FI 863471 A FI863471 A FI 863471A FI 863471 A FI863471 A FI 863471A FI 863471 A FI863471 A FI 863471A FI 863471 A FI863471 A FI 863471A
Authority
FI
Finland
Prior art keywords
preparation
acid derivatives
therapeutically useful
desmethylmevalonic
desmethylmevalonic acid
Prior art date
Application number
FI863471A
Other languages
English (en)
Finnish (fi)
Other versions
FI863471A0 (sv
FI90868B (sv
FI90868C (sv
Inventor
Gerhard Beck
Kerekjarto Bela Von
Hans-Hermann Lau
Guenther Wess
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19853530797 external-priority patent/DE3530797A1/de
Priority claimed from DE19863615446 external-priority patent/DE3615446A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI863471A0 publication Critical patent/FI863471A0/sv
Publication of FI863471A publication Critical patent/FI863471A/sv
Publication of FI90868B publication Critical patent/FI90868B/sv
Application granted granted Critical
Publication of FI90868C publication Critical patent/FI90868C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
FI863471A 1985-08-29 1986-08-27 Förfarande för framställning av terapeutiskt användbara 3-desmetylmevalonsyraderivat FI90868C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19853530797 DE3530797A1 (de) 1985-08-29 1985-08-29 3-desmethyl-mevalonsaeurederivate, verfahren zu ihrer herstellung pharmazeutische praeparate auf basis dieser verbindungen, ihre verwendung sowie zwischenprodukte
DE3530797 1985-08-29
DE3615446 1986-05-07
DE19863615446 DE3615446A1 (de) 1986-05-07 1986-05-07 3-desmethyl-mevalonsaeurederivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen, ihrer verwendung sowie zwischenprodukte

Publications (4)

Publication Number Publication Date
FI863471A0 FI863471A0 (sv) 1986-08-27
FI863471A true FI863471A (sv) 1987-03-01
FI90868B FI90868B (sv) 1993-12-31
FI90868C FI90868C (sv) 1994-04-11

Family

ID=25835463

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863471A FI90868C (sv) 1985-08-29 1986-08-27 Förfarande för framställning av terapeutiskt användbara 3-desmetylmevalonsyraderivat

Country Status (17)

Country Link
US (1) US4914127A (sv)
EP (1) EP0217092B1 (sv)
JP (1) JPH0830027B2 (sv)
KR (1) KR870002114A (sv)
AR (1) AR242206A1 (sv)
AU (1) AU583943B2 (sv)
CA (1) CA1294284C (sv)
DE (1) DE3669874D1 (sv)
DK (1) DK169127B1 (sv)
ES (1) ES2001595A6 (sv)
FI (1) FI90868C (sv)
GR (1) GR862210B (sv)
HU (1) HU195799B (sv)
IE (1) IE59312B1 (sv)
IL (1) IL79855A0 (sv)
NO (1) NO171108C (sv)
PT (1) PT83269B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789682A (en) * 1987-03-17 1988-12-06 Merck & Co., Inc. Antihypercholesterolemic compounds
DE3722809A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag 3-desmethyl-4-fluor-mevalonsaeurederivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen, ihre verwendung und zwischenprodukte
US4863957A (en) * 1987-12-21 1989-09-05 Rorer Pharmaceutical Corporation Novel HMG-CoA reductase inhibitors
US5470982A (en) * 1988-01-20 1995-11-28 Bayer Aktiengesellschaft Disubstituted pyridines
FR2669031A1 (fr) * 1990-11-09 1992-05-15 Rhone Poulenc Sante Procede de preparation de derives du tetrahydropyranne.
US5840620A (en) * 1994-06-15 1998-11-24 Seager; Carleton H. Method for restoring the resistance of indium oxide semiconductors after heating while in sealed structures
CN101570510B (zh) * 2008-04-30 2011-08-31 上海医药工业研究院 喹啉类化合物及其药物组合物、制备方法和应用
JP5789430B2 (ja) * 2011-06-27 2015-10-07 イハラニッケイ化学工業株式会社 ２−クロロメチルベンズアルデヒドの製造方法、２−クロロメチルベンズアルデヒド含有組成物及びその保管方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710513A (en) * 1979-08-17 1987-12-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4440927A (en) * 1981-06-19 1984-04-03 Merck & Co., Inc. Process for preparing inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase via a chiral synthon
CA1282425C (en) * 1984-06-04 1991-04-02 Meyer Sletzinger Process for preparing hmg-coa reductase inhibitors with a 3,5-dihydroxypentanoate subunit
US4588715A (en) * 1984-06-04 1986-05-13 Sandoz, Inc. Heptenoic acid derivatives
US4622338A (en) * 1985-03-11 1986-11-11 G. D. Searle & Co. Substituted glutaric acid lactones in the treatment of hyperlipidemia
FR2719387B1 (fr) * 1994-04-28 1996-05-24 Commissariat Energie Atomique Dispositif de contrôle de la position et/ou de la focalisation d'un faisceau lumineux focalisé.

Also Published As

Publication number Publication date
IE59312B1 (en) 1994-02-09
KR870002114A (ko) 1987-03-30
PT83269A (de) 1986-09-01
HU195799B (en) 1988-07-28
DK409986A (da) 1987-03-01
DK409986D0 (da) 1986-08-28
US4914127A (en) 1990-04-03
EP0217092B1 (de) 1990-03-28
NO171108C (no) 1993-01-27
ES2001595A6 (es) 1988-06-01
FI863471A0 (sv) 1986-08-27
FI90868B (sv) 1993-12-31
IL79855A0 (en) 1986-11-30
EP0217092A2 (de) 1987-04-08
FI90868C (sv) 1994-04-11
GR862210B (en) 1986-12-23
CA1294284C (en) 1992-01-14
AU583943B2 (en) 1989-05-11
HUT41757A (en) 1987-05-28
DK169127B1 (da) 1994-08-22
EP0217092A3 (en) 1987-06-16
IE862302L (en) 1987-02-28
PT83269B (pt) 1989-05-12
DE3669874D1 (de) 1990-05-03
AR242206A1 (es) 1993-03-31
NO863461L (no) 1987-03-02
JPH0830027B2 (ja) 1996-03-27
JPS6251641A (ja) 1987-03-06
NO863461D0 (no) 1986-08-28
NO171108B (no) 1992-10-19
AU6202886A (en) 1987-03-05

Similar Documents

Publication Publication Date Title
FI97297C (sv) Förfarande för framställning av terapeutiskt användbara boraminosyraderivat
FI892881A (sv) Förfarande för framställning av terapeutiskt användbara aminosyraderivat
PT87754A (pt) Process for the preparation of new amino acid derivatives
PT82342A (en) Process for the preparation of hialuronic acid derivatives
FI90976C (sv) Förfarande för framställning av nya terapeutiskt användbara indolderivat och deras syraadditionssalter
FI880941A (sv) Förfarande för framställning av terapeutiskt användbara piperazinyl-heterocykliska föreningar
FI850654L (sv) Förfarande för framställning av terapeutiskt användbara pleuromutilinderivator
FI874459A (sv) Förfarande för framställning av terapeutiskt användbara piperidinderivat
FI101857B1 (sv) Förfarande för framställning av ett nytt terapeutiskt användbart makrocykliskt aminofosfonsyrakomplex
PT87153A (pt) Process for the preparation of acid ribofuranuronic derivatives
FI872517A0 (sv) Förfarande för framställning av terapeutiskt användbara makrolidföreningar
FI883672A (sv) Förfarande för framställning av terapeutiskt användbara aminoalkoxifenylderivat
FI883997A (sv) Förfarande för framställning av terapeutiskt användbara substituerade 2-fenyl-4-kinolinkarboxylsyror
FI883889A0 (sv) Förfarande för framställning av nya terapeutiskt användbara aristeromycin/adenosinderivat
PT80546A (en) Process for the preparation of quinolinecarboxylic acid derivatives
FI93444B (sv) Förfarande för framställning av terapeutiskt aktiva dihydropyridinföreningar
FI871087A (sv) Förfarande för framställning av terapeutiskt användbara 1,2,3,4-tetrahydro-3-karbamoyl-2-tioxo/oxo-5-pyrimidinkarboxylsyraderivat
FI893936A0 (sv) Förfarande för framställning av terapeutiskt aktiva föreningar samt mellanprodukter
FI893003A (sv) Förfarande för framställning av terapeutiskt användbara neplanocinderivat
FI92064C (sv) Förfarande för framställning av terapeutiskt användbara N-bensopyranyllaktamer
FI890723A (sv) Förfarande för framställning av kinolinkarboxylsyraderivat
FI863471A (sv) Förfarande för framställning av terapeutiskt användbara 3-desmetylmevalonsyraderivat
FI884473A (sv) Förfarande för framställning av terapeutiskt användbara fenoxialkylpyrokatekolderivat
FI893434A (sv) Förfarande för framställning av nya terapeutiskt användbara cykloalkyltiazolderivat
FI92396B (sv) Nytt förfarande för framställning av metylendioxifenantrenföreningar

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT